Biomira, Cambridge Biotech Corp. deal

BIOMF (Edmonton) purchased CBCX's 54 percent interest in ADI Diagnostics for $1.5

Read the full 127 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE